Cargando…

Myasthenia Gravis

Detalles Bibliográficos
Autores principales:	Aarli, Johan A., Gilhus, Nils Erik, Lisak, Robert P., Mantegazza, Renato, Suzuki, Shigeaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE-Hindawi Access to Research 2011
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3270513/ https://www.ncbi.nlm.nih.gov/pubmed/22312479 http://dx.doi.org/10.4061/2011/697575

Ejemplares similares

Immunoactive treatment for myasthenia gravis; a Chinese experience
por: Gilhus, Nils Erik
Publicado: (2020)

Myasthenia Gravis: A Review of Available Treatment Approaches
por: Gilhus, Nils Erik, et al.
Publicado: (2011)

Advances and challenges in the treatment of myasthenia gravis
por: Schneider-Gold, Christiane, et al.
Publicado: (2021)

Myasthenia gravis, respiratory function, and respiratory tract disease
por: Gilhus, Nils Erik
Publicado: (2023)

User Involvement in Myasthenia Gravis Research
por: Gilhus, Nils Erik, et al.
Publicado: (2022)

Editorial: Phenotypes of myasthenia gravis
por: Li, Hai-Feng, et al.
Publicado: (2022)

Myasthenia Gravis Can Have Consequences for Pregnancy and the Developing Child
por: Gilhus, Nils Erik
Publicado: (2020)

Editorial: News and Views in the Management of Myasthenia Gravis
por: Evoli, Amelia, et al.
Publicado: (2021)

Complicating autoimmune diseases in myasthenia gravis: a review
por: Nacu, Aliona, et al.
Publicado: (2015)

Matrix Metalloproteinase-3 in Myasthenia Gravis Compared to Other Neurological Disorders and Healthy Controls
por: Luckman, Steven P., et al.
Publicado: (2011)

Complement Inhibition for the Treatment of Myasthenia Gravis
por: Mantegazza, Renato, et al.
Publicado: (2020)

B-Cell-Activating Factor and Autoimmune Myasthenia Gravis
por: Ragheb, Samia, et al.
Publicado: (2011)

Occurrence and severity of myasthenic crisis in an unselected Turkish cohort of patients with myasthenia gravis
por: Ozyurt Kose, Selen, et al.
Publicado: (2023)

Current and emerging therapies for the treatment of myasthenia gravis
por: Mantegazza, Renato, et al.
Publicado: (2011)

Animal models of myasthenia gravis: utility and limitations
por: Mantegazza, Renato, et al.
Publicado: (2016)

From Traditional to Targeted Immunotherapy in Myasthenia Gravis: Prospects for Research
por: Mantegazza, Renato, et al.
Publicado: (2020)

When myasthenia gravis is deemed refractory: clinical signposts and treatment strategies
por: Mantegazza, Renato, et al.
Publicado: (2018)

Impact of Ravulizumab on Patient Outcomes and Quality of Life in Generalized Myasthenia Gravis
por: Antozzi, Carlo, et al.
Publicado: (2023)

Autoantibodies to Agrin in Myasthenia Gravis Patients
por: Zhang, Bin, et al.
Publicado: (2014)

Repeated Acetylcholine Receptor Antibody-Concentrations and Association to Clinical Myasthenia Gravis Development
por: Heldal, Anne Taraldsen, et al.
Publicado: (2014)

Three Types of Striational Antibodies in Myasthenia Gravis
por: Suzuki, Shigeaki, et al.
Publicado: (2011)

Insights into the Classification of Myasthenia Gravis
por: Akaishi, Tetsuya, et al.
Publicado: (2014)

Diagnosis and therapy of myasthenia gravis—the patients’ perspective: a cross-sectional study
por: Sobierajski, Tomasz, et al.
Publicado: (2023)

Anemia in female patients with myasthenia gravis
por: Sekiguchi, Koji, et al.
Publicado: (2022)

Consistent improvement with eculizumab across muscle groups in myasthenia gravis
por: Mantegazza, Renato, et al.
Publicado: (2020)

Eculizumab improves fatigue in refractory generalized myasthenia gravis
por: Andersen, Henning, et al.
Publicado: (2019)

Case report: Seropositive myasthenia gravis complicated by limbic encephalitis positive for antibodies to AMPAR and Lgi1
por: Nes, Magne Solberg, et al.
Publicado: (2023)

Reappraisal of Oral Steroid Therapy for Myasthenia Gravis
por: Imai, Tomihiro, et al.
Publicado: (2020)

Ravulizumab pharmacokinetics and pharmacodynamics in patients with generalized myasthenia gravis
por: Vu, Tuan, et al.
Publicado: (2023)

Myasthenia gravis: Antigen presentation by thymoma epithelial cells
por: Gilhus, N.E., et al.
Publicado: (1994)

Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis
por: Andersen, Henning, et al.
Publicado: (2019)

International Consensus Guidance for Management of Myasthenia Gravis: 2020 Update
por: Narayanaswami, Pushpa, et al.
Publicado: (2021)

Flare of myasthenia gravis induced by COVID-19 vaccines
por: Ishizuchi, Kei, et al.
Publicado: (2022)

Headache Associated with Myasthenia Gravis: The Impact of Mild Ocular Symptoms
por: Nishimoto, Yoshinori, et al.
Publicado: (2011)

Iatrogenic Kaposi’s sarcoma in myasthenia gravis: learnings from two case reports
por: Frangiamore, Rita, et al.
Publicado: (2021)

International consensus guidance for management of myasthenia gravis: Executive summary
por: Sanders, Donald B., et al.
Publicado: (2016)

Myasthenia Gravis: Do the Subtypes Matter?
por: Murthy, J. M. K.
Publicado: (2020)

Immunoblot analysis of antiAChR antibodies in myasthenia gravis
por: Mantegazza, R., et al.
Publicado: (1988)

Altered Cardiac Autonomic Regulation in Individuals with Myasthenia Gravis—A Systematic Review and Meta-Analysis
por: Zawadka-Kunikowska, Monika, et al.
Publicado: (2023)

Total drug treatment and comorbidity in myasthenia gravis: a population-based cohort study
por: Andersen, J B, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ip8d4mjc1l607d2ni43uplu6lv